Small Cap Awards 2022 – Meet the nominees for Aquis Company of the Year
The Small Cap Awards celebrate the best in UK businesses with market capitalisation of below £200 million. The awards will…
2 years ago
Partner Content
Why fine wine is the alternative investment you should consider
The need to think more broadly has seen an increasing number of investors move away from traditional investments and seek…
2 years ago
Investing in Art: A Beginner’s Guide
Many potential investors still find the art world somewhat intimidating and aren't sure where to begin, but here are five…
2 years ago
Can you survive? This is a clear and present wealth warning – for every British investor today
In a matter of weeks, we’ve seen years of growth wiped out. Now is the time to take action.
2 years ago
3 investing lessons from Angel Insights with Sarah Turner
A few takeaways for investors from crowdfunding experts SyndicateRoom's latest podcast.
3 years ago
Breaking down the barriers to ownership: How WiseAlpha built an open bond marketplace
Rezaah Ahmad, CEO of WiseAlpha, gives the inside track on how his company is driving down barriers to ownership with…
3 years ago
We are what we eat: Jim Mellon exclusive
Longevity, biotech, investment, sustainability and ethics: Jim Mellon’s new book, MOO’S LAW, addresses the opportunities and challenges of our need…
3 years ago
Busting some of the common myths about investing in private equity
Helen Steers, Partner at Pantheon and Manager of Pantheon International Plc (PIP), addresses some of the common myths surrounding private…
4 years ago
Longevity market blockbuster? Senolytic drug development is attracting investor interest
By killing so-called zombie cells which accelerate the ageing process, drugs called senolytics promise to keep us younger and fitter…
4 years ago
Longevity Market Watch: The Longevity doctor will see you now
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
4 years ago